SUNRISE, Fla.--(BUSINESS WIRE)--Bioheart, Inc. (OTCBB:BHRT) offers yet another medical breakthrough with the next-level stem cell treatment for cardiac patients. The stem cells aid in limiting damage due to a cardiac event and promote angiogenesis or formation of new blood vessels.
